Johnson & Johnson’s Innovate Reconciliation Action Plan
July 2018 – July 2020

We are honoured to introduce our second Reconciliation Action Plan (RAP) for the Johnson &Johnson Family of Companies in Australia.

Johnson & Johnson is guided by the values in Our Credo. Put simply, Our Credo challenges us to put the needs and wellbeing of the people we serve first. Specifically, Paragraph three of Our Credo emphasises our commitment to support the communities in which we live and work, and to the world community as well.

The Johnson & Johnson Innovate Reconciliation Action Plan provides a framework to the development of deeper engagement with Aboriginal and Torres Strait Islander communities through improved cultural awareness. It also allows our organisation to be aspirational and innovative to help us gain a deeper understanding of our sphere of influence and establish the best approach to advance reconciliation.

Our vision for reconciliation is that Aboriginal and Torres Strait Islander peoples live longer, healthier, happier lives.

To commemorate the Johnson & Johnson Family of Companies Innovate RAP, artwork by Sarrita King and Tarisse King was commissioned. Embracing Our Country Through Connection is a bespoke collaborative artwork painted by the King Sisters representing the connection between all things in life especially through the land which connects us to our ancestors.

Embracing Our Country Through Connection

Artists: Tarisse King & Sarrita King
Community: Gurindji, NT / Waanyi, QLD
Medium: Acrylic on canvas
Dimensions: 90cm x 90cm
Year Created: 2018

This artwork was commissioned for the Johnson & Johnson Innovate RAP Statement and the original artwork is proudly displayed in the Sydney Head office.

Embracing Our Country Through Connection

Working in partnership to address health outcomes

The Janssen Pharmaceutical Companies of Johnson & Johnson is committed to providing patients and healthcare professionals with access to the information, programs and support they need to achieve the best health outcomes possible.

First Australians suffer a much higher burden of disease from Rheumatoid Arthritis and Lupus than other Australians. As a leader in healthcare, we know we cannot close the gap in outcomes alone. It is our responsibility to work in partnership so together with partners, we can develop deeper engagement, understanding and cultural awareness.

Janssen has been proud to partner with Dragon Claw to support their innovative project in Central Australia. Talkin' Straight provides disease education for patients living with Rheumatoid Arthritis and Lupus in four community languages, Arrernte, Luritja, Pitjantjatjara and Walpiri.

For more information about the Johnson & Johnson Family of Companies Innovate RAP please click here.